Successfully reported this slideshow.
We use your LinkedIn profile and activity data to personalize ads and to show you more relevant ads. You can change your ad preferences anytime.

Stock Research Report for LLY as of 6/23/11 - Chaikin Power Tools


Published on

To order a free Chaikin Power Gauge stock research report for LLY go to

Published in: Business, Economy & Finance
  • Be the first to comment

  • Be the first to like this

Stock Research Report for LLY as of 6/23/11 - Chaikin Power Tools

  1. 1. LILLY ELI & CO (LLY) Price: $37.68 Industry: Drugs Chaikin Power Gauge Report | Generated: Thu Jun 23 13:39 EDT 2011 LLY LILLY ELI & CO $37.68 Power Gauge Rating LLY - Very Bullish TM The Chaikin Power Gauge Rating for LLY is very bullish due to very attractive financial metrics, very positive expert opinions and bullish price/volume activity. The rating also reflects weak earnings performance. Financial Metrics LLYs financial metrics are excellent due to a high return on equity and low Earnings Performance price to sales ratio. Price/Volume Activity Expert Opinions News Sentiment Rating Neutral LLY LILLY ELI & CO June 22, 2011 TM Chaikin Sentiment Gauge for LLY is neutral. Stories concerning LLY have a balanced or neutral sentiment. News Sentiment :Neutral Power Trend - 5 Year Chart The Power Gauge distills a 20 factor model into a concise picture of a stocks potential. High Potential Neutral Low PotentialI want to receive special offers about trading stocks with your brokerage partner, optionsXpress. Click here
  2. 2. Financials & Earnings Financial Metrics Financial Metrics Rating LT Debt/Equity Ratio Very Bullish Price to Book Value LLYs financial metrics are excellent. The company yields a high return on shareholders equity and has high revenue per share. Return on Equity The rank is based on a high long term debt to equity ratio, high price to book value ratio, high return on equity, low price to sales ratio and relatively high cash Price to Sales Ratio flow. Business Value Assets and Liabilities Valuation Returns Ratio TTM Ratio TTM Ratio TTM Current Ratio 2.01 Price/Book 3.13 Return on Invest 28.5% LT Debt/Equity 0.55 Price/Sales 1.89 Return on Equity 43.4% Earnings Performance Earnings Performance Rating Earnings Growth Bearish Earnings Surprise LLYs earnings performance has been weak. The company is priced relatively high compared to next years projected EPS and has an erratic 5 year earnings trend. Earnings Trend The rank is based on high earnings growth over the past 3-5 years, a relatively Projected P/E Ratio high projected P/E ratio and inconsistent earnings over the past 5 years. Earnings Consistency 5 Year Revenue and Earnings Growth EPS Estimates 12/06 12/07 12/08 12/09 12/10 Factor Actual EPS Prev EST EPS Current Change Revenue(M) 15,691.00 18,633.50 20,378.00 21,836.00 23,076.00 Quarterly EPS $1.22 $1.17 -0.05 Rev % Growth 7.14% 18.75% 9.36% 7.15% 5.68% Yearly EPS $4.58 $4.27 -0.31 EPS $2.45 $2.71 $-1.89 $3.94 $4.58 Factor Actual EPS Growth Est EPS Growth Change EPS % Growth 34.62% 10.61% -169.74% 308.47% 16.24% 3-5 year EPS 9.62% -4.38% -14.00 EPS Surprise EPS Quarterly Results Estimate Actual Difference % Difference FY Qtr 1 Qtr 2 Qtr 3 Qtr 4 Total Latest Qtr $1.17 $1.24 $0.07 5.98 12/09 $1.20 $1.06 $0.86 $0.83 $3.95 1 Qtr Ago $1.10 $1.11 $0.01 0.91 12/10 $1.13 $1.22 $1.18 $1.05 $4.58 2 Qtr Ago $1.15 $1.21 $0.06 5.22 12/11 $0.95 - - - - 3 Qtr Ago $1.11 $1.24 $0.13 11.71 Fiscal Year End Month is December. I want to receive special offers about trading stocks with your brokerage partner, optionsXpress. Click here
  3. 3. Price Trend & Expert Opinions Price/Volume Activity Price/Volume Activity Rating Relative Strength vs Market Bullish Chaikin Money Flow Price and volume activity for LLY is bullish. LLY has outperformed the S&P 500 over 26 weeks and has a rising price trend. Price Trend The rank for LLY is based on its price strength versus the market, a positive Price Trend ROC Chaikin price trend and a negative Chaikin price trend ROC. Volume Trend Relative Strength vs S&P500 Index Chaikin Money Flow Chart shows whether LLY is performing better or worse than the market. Chaikin Money Flow analyzes supply and demand for a companys stock. Price Activity Price Activity Volume Activity Factor Value Factor Value Factor Value 52 Week High 39.15 % Change Price - 4 Weeks -1.64% Average Volume 20 Days 6,527,498 52 Week Low 33.12 % Change Price - 24 Weeks 8.34% Average Volume 90 Days 7,134,977 % Change YTD Rel S&P 500 5.37% % Change Price - 4 Wks Rel to S&P 0.90% Chaikin Money Flow Persistency 58% % Change Price - 24 Wks Rel to S&P 7.45% Expert Opinions Expert Opinions Earnings Estimate Revisions Very Bullish Short Interest Expert opinions about LLY are very positive. Insiders are net buyers of LLYs stock and analystss opinions on LLY have been more positive recently. Insider Activity The rank for LLY is based on analysts revising earnings estimates upward, a low short interest ratio, insiders purchasing stock, optimistic analyst opinions and Analyst Opinions price strength of the stock versus the Drugs industry group. Relative Strength vs Industry Earnings Estimate Revisions Analyst Recommendations EPS Estimates Revision Summary Current 7 Days Ago % Change Factor Value Last Week Last 4 Weeks Current Qtr 1.17 1.17 0.00% Mean this Week Hold Up Down Up Down Next Qtr 1.08 1.08 0.00% Mean Last Week Hold Curr Qtr 0 0 0 0 Curr Yr 0 0 1 0 Current 30 Days Ago % Change Change 0.00 Next Qtr 0 0 0 0 Current FY 4.27 4.27 0.00 Mean 5 Weeks Ago Hold Next Yr 0 0 1 1 I want to receive special offers about trading stocks with your brokerage partner, optionsXpress. Click here
  4. 4. The Company & Its Competitors LLYs Competitors in Drugs News Headlines for LLY Company Power Historic EPS Projected EPS Profit Margin PEG PE Revenue(M) EU approves Lillys weekly diabetes drug Gauge growth growth Bydureon - Jun 21, 2011 LLY 9.62% -4.38% 20.82% -2.02 7.85 23,076 Lilly for Better Healthâ„¢ Launches Enhanced MRK 18.19% 3.34% 3.48% 2.87 10.10 45,987 Multi-Channel Patient Education Platform - Jun 14, 2011 JNJ 4.21% 6.03% 19.77% 2.22 13.71 61,587 Judge orders drug company to pay SC $327 NVS 9.55% 4.92% 18.64% 2.25 11.84 50,624 million - Jun 3, 2011 Peregrine Appoints Jeffrey Masten as Vice PFE 6.66% 3.06% 12.51% 2.97 9.09 67,809 President - May 31, 2011 GSK 3.26% 4.10% 6.89% 2.70 14.24 45,905 Lilly USA, LLC Launches TruAssist for Patients - May 16, 2011 Company Details Company Profile LILLY ELI & CO Eli Lilly and Company discovers, develops, manufactures, and sells products in one LILLY CORPORATE CTR significant business segment -pharmaceutical products. The company directs its INDIANAPOLIS, IN 46285 research efforts primarily toward the search for products to diagnose, prevent and treat USA human diseases. The company also conducts research to find products to treat diseases Phone: 3172762000 in animals and to increase the efficiency of animal food production. Fax: 317-276-4878 Website: http:// Full Time Employees: 38,350 Sector: Medical Power Gauge Ratings are created using a relative ranking system that assigns a rank of 0 to 100 (100 being the highest) to each stock in the universe. Rank is calculated by evaluating each of the stocks factors and combining them into a single number using a weighting formula. A stocks rank ranges from 100-0, where 100 is the strongest, and a rank of 95 indicates the stock is better than 95% of the stocks in the universe. Chaikin Stock Research(CSR) is not registered as a securities broker dealer or investment advisor with either the U.S. Securities and Exchange Commission or with any state securities regulatory authority. CSR is not responsible for trades executed by users of this research report, our web site or mobile app based on the information included herein. The information presented in this report does not represent a recommendation to buy or sell stocks or any financial instrument nor is it intended as an endorsement of any security or investment. The information in this report is generic by nature and is not personalized to the specific financial situation of any individual. The user bears complete responsibility for their own investment research and should seek the advice of a qualified investment professional before making any investment decisions. Copyright (c) 1978-(Present) by ZACKS Investment Research, Inc ("ZACKS"). The information, data, analyses and opinions contained herein (1) includes the confidential and proprietary information of ZACKS, (2) may not be copied or redistributed, for any purpose, (3) does not constitute investment advice offered by ZACKS, (4) are provided solely for informational purposes, and (5) are not warranted or represented to be correct, complete, accurate or timely. ZACKS shall not be responsible for investment decisions, damages or other losses resulting from, or related to, use of this information, data, analyses or opinions. Past performance is no guarantee of future performance. ZACKS is not affiliated with Chaikin Power Tools. This report from Chaikin Power Tools is for informational purposes only and is not a recommendation to buy or sell securities. LM 2.3 DS 3.0 LS 2.1 Data Provided by ZACKS Investment Research, Inc., Special offers to trade stocks from optionsXpress: